Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,454 | 80,336 | 52,214 | 101,136 | 92,795 |
| Marketable Securities | 188,293 | 153,721 | 293,584 | 53,153 | 92,975 |
| Other current assets | 0 | 0 | 0 | 300,000 | 0 |
| TOTAL | $249,601 | $240,181 | $351,399 | $459,562 | $190,687 |
| Non-Current Assets | |||||
| PPE Net | 9,964 | 12,956 | 15,311 | 17,563 | 19,528 |
| Other Non-Current Assets | 24,417 | 32,779 | 38,173 | 42,649 | 45,379 |
| TOTAL | $34,381 | $45,735 | $53,484 | $60,212 | $64,907 |
| Total Assets | $283,982 | $285,916 | $404,883 | $519,774 | $255,594 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,785 | 6,260 | 5,414 | 3,819 | 3,680 |
| Accrued Expenses | 8,531 | 9,108 | 11,001 | 9,562 | 9,161 |
| TOTAL | $66,989 | $58,436 | $55,205 | $48,692 | $18,846 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 19,654 |
| Deferred Revenues | 45,606 | 34,550 | 32,820 | 28,317 | 2,024 |
| Other Non-Current Liabilities | 28,064 | 36,555 | 45,566 | 51,481 | 58,361 |
| TOTAL | $262,521 | $304,670 | $349,566 | $374,211 | $90,561 |
| Total Liabilities | $329,510 | $363,106 | $404,771 | $422,903 | $109,407 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,612 | 42,566 | 41,804 | 41,422 | 36,817 |
| Common Shares | 6 | 4 | 4 | 4 | 4 |
| Retained earnings | -558,184 | -471,564 | -373,138 | -264,256 | -162,936 |
| Other shareholders' equity | 135 | -826 | -3,986 | -10 | -7 |
| TOTAL | $-45,528 | $-77,190 | $112 | $96,871 | $146,187 |
| Total Liabilities And Equity | $283,982 | $285,916 | $404,883 | $519,774 | $255,594 |